| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_445b6681ae8928a1936ea9e6f7f96403 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 |
| filingDate |
2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6447a864dae8145bda40a2cba7c8dae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb3fe975defa44117cf058d9fdf97fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446655330432886b7d44060f6f1a78fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b431ab2af3dd544575987c6832ea6ceb |
| publicationDate |
2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114854772-A |
| titleOfInvention |
Varicella-zoster virus mRNA vaccine and preparation method and application thereof |
| abstract |
The invention relates to the field of nucleic acid vaccines, in particular to a varicella-zoster mRNA vaccine and a preparation method and application thereof. The mRNA encoding the varicella-zoster virus antigen provided by the present invention contains the coding region encoding the glycoprotein E of the varicella-zoster virus, and the mRNA can induce specific antibody responses against glycoprotein E and CD4+T when the mRNA is delivered to the body. cellular response. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116355917-A |
| priorityDate |
2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |